Paradigm Therapeutics Overview
- Founded
-
1999

- Status
-
Acquired/Merged
- Employees
-
17

- Latest Deal Type
-
M&A
Paradigm Therapeutics General Information
Description
Developer of drugs combining model genetics and bioinformatics. The company provides target identification and validation services based on gene knock out technology and in vivo pharmacology. The company has developed a drug discovery pipeline comprising targets and late stage pre-clinical projects in pain, CNS disorders, hormone dependent diseases such as prostate and breast cancer and metabolic diseases such as diabetes, hyperlipidemias, obesity and osteoporosis.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 214 Cambridge Science Park
- Cambridge CB4 0WA
- England, United Kingdom
+44 01223 000000
Paradigm Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 31-Mar-2007 | 000.00 | Completed | Generating Revenue | ||
4. Later Stage VC | 07-Jul-2006 | 000.00 | 000.00 | Completed | Generating Revenue | |
3. Early Stage VC | 00.000 | 000.00 | Completed | |||
2. Early Stage VC | 09-Dec-2002 | $18.9M | $18.9M | Completed | Product Development | |
1. Early Stage VC | 01-Dec-2000 | Completed | Product Development |
Paradigm Therapeutics Patents
Paradigm Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20070101444-A1 | Ion channel | Abandoned | 08-Apr-2004 | 00000000000 | |
US-20060242724-A1 | Receptor | Abandoned | 08-Oct-2003 | 00000000000 | |
JP-2007505617-A | Receptor | Pending | 19-Sep-2003 | 00000000000 | |
EP-1662862-A1 | Receptor | Withdrawn | 19-Sep-2003 | 00000000000 | |
CA-2539127-A1 | Receptor | Abandoned | 19-Sep-2003 | C12N15/8509 |
Paradigm Therapeutics Signals
Paradigm Therapeutics Former Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Avlar BioVentures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Bio*One Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
EDBI | Venture Capital | Minority | 000 0000 | 000000 0 | |
Excalibur Group Holdings | Venture Capital | Minority | 000 0000 | 000000 0 | |
Genmab | Corporation | Minority | 000 0000 | 000000 0 |